Literature DB >> 14059066

THE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL.

B W CROMIE.   

Abstract

Keywords:  ANALGESICS AND ANTIPYRETICS; ANTIDEPRESSIVE AGENTS; ASPIRIN; DRUG HYPERSENSITIVITY; PHARMACOLOGY; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS

Mesh:

Substances:

Year:  1963        PMID: 14059066     DOI: 10.1016/s0140-6736(63)90693-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Comparison of aspirin and benorylate in the treatment of rheumatoid arthritis.

Authors:  D L Beales; H C Burry; R Grahame
Journal:  Br Med J       Date:  1972-05-27

2.  Simple analgesics for arthritis.

Authors:  E C Huskisson
Journal:  Br Med J       Date:  1974-10-26

3.  Reflections on controlled trial.

Authors:  A B Hill
Journal:  Ann Rheum Dis       Date:  1966-03       Impact factor: 19.103

4.  Validity of cross-over trials.

Authors:  D W Vere
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

5.  Some problems in the statistical analysis of clinical trial data.

Authors:  P Armitage
Journal:  Proc R Soc Med       Date:  1966

6.  [Double or single blind test in a short term pharmacologic experiment? Effect of psychopharmaca on the function of the autonomic nervous system in healthy persons in this experiment].

Authors:  A W von Eiff; H J Jesdinsky; H H Hennekeuser; M Weimer; I Albinus
Journal:  Klin Wochenschr       Date:  1966-11-01

7.  Double-blind cross-over study of ketoprofen and ibuprofen in management of rheumatoid arthritis.

Authors:  S B Mills; M Bloch; F E Bruckner
Journal:  Br Med J       Date:  1973-10-13

8.  Cimetidine suspension as adjuvant to energy restricted diet in treating obesity.

Authors:  M H Rasmussen; T Andersen; L Breum; P C Gøtzsche; J Hilsted
Journal:  BMJ       Date:  1993-04-24

9.  Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis.

Authors:  A Calin; R Grahame
Journal:  Br Med J       Date:  1974-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.